Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

September 25, 2016

Study Completion Date

September 25, 2016

Conditions
Impairment of Gastric EmptyingAcute Phase of Myocardial Infarction
Interventions
DRUG

Paracetamol concentration time curve from 0 to 120 min

It consists in oral ingestion of 1.5g of paracetamol (Contents of 3 Doliprane® capsules 500 mg) and 60 mg prasugrel (6 tablets Efient ® 10 mg) or 180 mg ticagrelor ( 2 tablets Brilique ® 90 mg) with water. Then Paracetamol concentration is followed by the realization of the curve of concentration of paracetamol in plasma samples. These samples are taken at 15 min intervals during the first 2 hours.

Trial Locations (1)

33604

CHU de Bordeaux - Hôpital du Haut Lévèque, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02251249 - Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study. | Biotech Hunter | Biotech Hunter